Other news

u-card-img-1
News

2023 George Eisenbarth Memorial Lecture award

Decio L. Eizirik (WEL Research Institute - ULB) is the recipient of the prestigious George Eisenbarth Memorial Lecture that will be delivered at the 15th annual Network for Pancreatic Organ Donors with Diabetes (nPOD) meeting in Florida, USA.

Learn more
u-card-img-1
News

2023 Earl P. Benditt Award

Miikka Vikkula (WEL Research Institute - UCLouvain) is the recipient of the prestigious Earl P. Benditt Award which he will receive at the 2023 edition of the North American Vascular Biology Organization (NAVBO) meeting in Rhode Island, USA.

Learn more
u-card-img-1
News
Publication in Nucleic Acids Research

« Z » for Zalpha

Alain Vanderplasschen (WEL Research Institute – ULiège) and his team demonstrated a key role for the Zalpha protein domain of Cyprinid herpesvirus 3 in the mechanism of viral infection in carp.  

Learn more
u-card-img-1
News
Publication in Blood

GARP in cancer: the story continues…

Sophie Lucas’ team (WEL Research Institute - UCLouvain) showed that the strategy of blocking GARP, a novel immuno-oncology target under clinical investigation for solid cancers, also has potential in "liquid" tumours.

Learn more
u-card-img-1
News

Launch of the 2022 « WEL-T Investigator Programme” call!

Opening on 15 December 2022 of the first "WEL-T Investigator Programme" call.

The recording of the Dec 09 information webinar in English is available here.

Learn more
u-card-img-1
News

WELBIO asbl becomes the WEL Research Institute

The WEL Research Institute supports strategic research of excellence within its departments: WELBIO (life sciences) and WEL-T (engineering sciences, chemistry, physics) for an impact in health and sustainable transition.

Learn more
u-card-img-1
News

Rentrée des chercheuses et chercheurs WELBIO

La « Rentrée des Chercheuses et des Chercheurs WELBIO » fut l’occasion pour WELBIO de présenter sa stratégie et ses grands axes de développement, ainsi que quelques programmes de recherche dans différents domaines, à différents stades d’évolution.

Learn more
u-card-img-1
News
Publication dans Nature Communications

Des cellules cibles pour l'immunothérapie du cancer

David Vermijlen (WELBIO – ULB) et son équipe décrivent les mécanismes du développement des cellules T γδ du système immunitaire qui sont des cibles particulièrement attrayantes pour l'immunothérapie du cancer. 

Learn more
u-card-img-1
News
Publication in Science Advances

Diabetes: At the heart of the 'battle' leading to beta cell loss

Decio Eizirik's team (WELBIO-ULB) demonstrates the dual role played by NLRC5 within beta cells in the early stages of the disease.

Learn more
u-card-img-1
News
Invitation

Rentrée des chercheuses et chercheurs WELBIO

Vendredi 7 octobre prochain, de 12 à 14h
Aux Moulins de Beez (Namur)
➡ Infos et inscription ici  

Learn more
u-card-img-1
News
Spin-off creation

THERAtRAME : Artificial intelligence to fight cancer

THERAtRAME SA, a new spin-off of the University of Liège and WELBIO, secures €4.5M seed financing to develop novel cancer medicines in the field of tRNA epitranscriptomics.

Learn more
u-card-img-1
News
Publication in EMBO J

Role of ELP3 in macrophage polarization

Alain Chariot (WELBIO – ULiège) and his team demonstrated  the key role of ELP3-mediated tRNA modifications in the biology of immune cells.

Learn more

Share this page